Oasmia

Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

Read more
Interim report May – October 2019

Read the report

Press releases

January 9, 2020
Oasmia to present at Biotech Showcase in San Francisco
December 30, 2019 Regulatory press release
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
December 30, 2019 Regulatory press release
Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – October 31, 2019

All press releases

Financial reports

Calendar

March 27, 2020 Interim Report May 2019 – January 2020
June 18, 2020 Year-end Report May 2019 – April 2020

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK